Chronic nicotine modifies skeletal muscle Na,K-ATPase activity through its interaction with the nicotinic acetylcholine receptor and phospholemman

PLoS One. 2012;7(3):e33719. doi: 10.1371/journal.pone.0033719. Epub 2012 Mar 19.

Abstract

Our previous finding that the muscle nicotinic acetylcholine receptor (nAChR) and the Na,K-ATPase interact as a regulatory complex to modulate Na,K-ATPase activity suggested that chronic, circulating nicotine may alter this interaction, with long-term changes in the membrane potential. To test this hypothesis, we chronically exposed rats to nicotine delivered orally for 21-31 days. Chronic nicotine produced a steady membrane depolarization of ∼3 mV in the diaphragm muscle, which resulted from a net change in electrogenic transport by the Na,K-ATPase α2 and α1 isoforms. Electrogenic transport by the α2 isoform increased (+1.8 mV) while the activity of the α1 isoform decreased (-4.4 mV). Protein expression of Na,K-ATPase α1 or α2 isoforms and the nAChR did not change; however, the content of α2 subunit in the plasma membrane decreased by 25%, indicating that its stimulated electrogenic transport is due to an increase in specific activity. The physical association between the nAChR, the Na,K-ATPase α1 or α2 subunits, and the regulatory subunit of the Na,K-ATPase, phospholemman (PLM), measured by co-immuno precipitation, was stable and unchanged. Chronic nicotine treatment activated PKCα/β2 and PKCδ and was accompanied by parallel increases in PLM phosphorylation at Ser(63) and Ser(68). Collectively, these results demonstrate that nicotine at chronic doses, acting through the nAChR-Na,K-ATPase complex, is able to modulate Na,K-ATPase activity in an isoform-specific manner and that the regulatory range includes both stimulation and inhibition of enzyme activity. Cholinergic modulation of Na,K-ATPase activity is achieved, in part, through activation of PKC and phosphorylation of PLM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Gene Expression Regulation, Enzymologic / drug effects
  • Male
  • Membrane Potentials / drug effects
  • Membrane Proteins / metabolism*
  • Muscle Proteins / metabolism*
  • Muscle, Skeletal / metabolism*
  • Nicotine / pharmacokinetics*
  • Nicotinic Agonists / pharmacology*
  • Phosphoproteins / metabolism*
  • Phosphorylation / drug effects
  • Phosphorylation / genetics
  • Protein Kinase C / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Nicotinic / metabolism*
  • Sodium-Potassium-Exchanging ATPase / biosynthesis*

Substances

  • Membrane Proteins
  • Muscle Proteins
  • Nicotinic Agonists
  • Phosphoproteins
  • Receptors, Nicotinic
  • phospholemman
  • Nicotine
  • Protein Kinase C
  • Atp1a1 protein, rat
  • Atp1a2 protein, rat
  • Sodium-Potassium-Exchanging ATPase